Pharmacy alerts

Gabapentin Relonchem 50mg/ml Oral Solution

Class 4 medicines defect notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution.

Benzylpenicillin benzathine powder for suspension for injection defect

Class 4 medicines defect notification: Brancaster Pharma Limited, benzylpenicillin benzathine 1.2 million I.U. and 2.4 million I.U. powder for suspension for injection

Personal protective equipment and heat: risk of heat stress

Urgent public health message to healthcare providers and professionals regarding the risk of heat stress when using PPE.

ACE-inhibitors: the distinction between bradykinin- and histamine-mediated angioedema

The MHRA has published a drug safety update on ACE-inhibitors and the distinction between bradykinin- and histamine-mediated angioedema.

Orbit Pharma Limited, cyclizine lactate 50mg/ml solution for injection recall

The MHRA has published a class 3 medicines recall for cyclizine lactate 50mg/ml solution for injection.

Cadila Pharmaceuticals Limited, mirtazapine 30mg tablets defect

The MHRA has published a class 4 medicines defect notification for mirtazapine 30mg tablets.